才田 聡

Last Update: 2021/06/10 15:06:56

Print

Name(Kanji/Kana/Abecedarium Latinum)
才田 聡/サイダ サトシ/Satoshi Saida
Primary Affiliation(Org1/Job title)
Kyoto University Hospital Kyoto University Hospital/Program-Specific Assistant Professor, University Hospital
Academic Degree
Field(Japanese) Field(English) University(Japanese) University(English) Method
博士(医学) 京都大学
researchmap URL
https://researchmap.jp/7000009572
Research Topics
(Japanese)
血液学、白血病、悪性腫瘍
(English)
Hematology, Leukemia, Oncology
Fields of research (key words)
Key words(Japanese) Key words(English)
白血病 Leukeimia
Published Papers
Author Author(Japanese) Author(English) Title Title(Japanese) Title(English) Bibliography Bibliography(Japanese) Bibliography(English) Publication date Refereed paper Language Publishing type Disclose
Saida S, Zhen T, Kim E, Yu K, Lopez G, McReynolds LJ, Liu PP Saida S, Zhen T, Kim E, Yu K, Lopez G, McReynolds LJ, Liu PP Saida S, Zhen T, Kim E, Yu K, Lopez G, McReynolds LJ, Liu PP Gata2 deficiency delays leukemogenesis while contributing to aggressive leukemia phenotype in Cbfb-MYH11 knockin mice. Gata2 deficiency delays leukemogenesis while contributing to aggressive leukemia phenotype in Cbfb-MYH11 knockin mice. Gata2 deficiency delays leukemogenesis while contributing to aggressive leukemia phenotype in Cbfb-MYH11 knockin mice. Leukemia Leukemia Leukemia 2019/10 Refereed Disclose to all
Saida Satoshi, Zhen Tao, Kwon Erika Mijin, Lopez Guadalupe, Liu Paul P Saida Satoshi, Zhen Tao, Kwon Erika Mijin, Lopez Guadalupe, Liu Paul P Saida Satoshi, Zhen Tao, Kwon Erika Mijin, Lopez Guadalupe, Liu Paul P Distinct Roles of GATA2 in Development and Evolution of CBFB-MYH11 AML Distinct Roles of GATA2 in Development and Evolution of CBFB-MYH11 AML Distinct Roles of GATA2 in Development and Evolution of CBFB-MYH11 AML BLOOD, 132 BLOOD, 132 BLOOD, 132 2018/11/29 Refereed Disclose to all
Kubota H, Saida S, Kouzuki K, Hamabata T, Daifu T, Kato I, Umeda K, Hiramatsu H, Nishikomori R, Heike T, Okamoto T, Adachi S Kubota H, Saida S, Kouzuki K, Hamabata T, Daifu T, Kato I, Umeda K, Hiramatsu H, Nishikomori R, Heike T, Okamoto T, Adachi S Kubota H, Saida S, Kouzuki K, Hamabata T, Daifu T, Kato I, Umeda K, Hiramatsu H, Nishikomori R, Heike T, Okamoto T, Adachi S [Pediatric acute lymphoblastic leukemia presenting with bone and joint pain]. [Pediatric acute lymphoblastic leukemia presenting with bone and joint pain]. [Pediatric acute lymphoblastic leukemia presenting with bone and joint pain]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 59, 2, 167-173 [Rinsho ketsueki] The Japanese journal of clinical hematology, 59, 2, 167-173 [Rinsho ketsueki] The Japanese journal of clinical hematology, 59, 2, 167-173 2018 Refereed Disclose to all
Satoshi Saida Satoshi Saida Satoshi Saida Predispositions to Leukemia in Down Syndrome and Other Hereditary Disorders Predispositions to Leukemia in Down Syndrome and Other Hereditary Disorders Predispositions to Leukemia in Down Syndrome and Other Hereditary Disorders CURRENT TREATMENT OPTIONS IN ONCOLOGY, 18, 7, 41 CURRENT TREATMENT OPTIONS IN ONCOLOGY, 18, 7, 41 CURRENT TREATMENT OPTIONS IN ONCOLOGY, 18, 7, 41 2017/07 Refereed English Disclose to all
Satoshi Saida Satoshi Saida Satoshi Saida Evolution of myeloid leukemia in children with Down syndrome Evolution of myeloid leukemia in children with Down syndrome Evolution of myeloid leukemia in children with Down syndrome INTERNATIONAL JOURNAL OF HEMATOLOGY, 103, 4, 365-372 INTERNATIONAL JOURNAL OF HEMATOLOGY, 103, 4, 365-372 INTERNATIONAL JOURNAL OF HEMATOLOGY, 103, 4, 365-372 2016/04 Refereed English Research paper(scientific journal) Disclose to all
Satoshi Saida, Katsutsugu Umeda, Takahiro Yasumi, Akane Matsumoto, Itaru Kato, Hidefumi Hiramatsu, Osamu Ohara, Toshio Heike, Souichi Adachi Satoshi Saida, Katsutsugu Umeda, Takahiro Yasumi, Akane Matsumoto, Itaru Kato, Hidefumi Hiramatsu, Osamu Ohara, Toshio Heike, Souichi Adachi Satoshi Saida, Katsutsugu Umeda, Takahiro Yasumi, Akane Matsumoto, Itaru Kato, Hidefumi Hiramatsu, Osamu Ohara, Toshio Heike, Souichi Adachi Successful reduced-intensity stem cell transplantation for GATA2 deficiency before progression of advanced MDS Successful reduced-intensity stem cell transplantation for GATA2 deficiency before progression of advanced MDS Successful reduced-intensity stem cell transplantation for GATA2 deficiency before progression of advanced MDS PEDIATRIC TRANSPLANTATION, 20, 2, 333-336 PEDIATRIC TRANSPLANTATION, 20, 2, 333-336 PEDIATRIC TRANSPLANTATION, 20, 2, 333-336 2016/03 Refereed English Research paper(scientific journal) Disclose to all
Atsushi Nemoto, Satoshi Saida, Itaru Kato, Jiro Kikuchi, Yusuke Furukawa, Yasuhiro Maeda, Koshi Akahane, Hiroko Honna-Oshiro, Kumiko Goi, Keiko Kagami, Shinya Kimura, Yuko Sato, Seiichi Okabe, Akira Niwa, Kenichiro Watanabe, Tatsutoshi Nakahata, Toshio Heike, Kanji Sugita, Takeshi Inukai Atsushi Nemoto, Satoshi Saida, Itaru Kato, Jiro Kikuchi, Yusuke Furukawa, Yasuhiro Maeda, Koshi Akahane, Hiroko Honna-Oshiro, Kumiko Goi, Keiko Kagami, Shinya Kimura, Yuko Sato, Seiichi Okabe, Akira Niwa, Kenichiro Watanabe, Tatsutoshi Nakahata, Toshio Heike, Kanji Sugita, Takeshi Inukai Atsushi Nemoto, Satoshi Saida, Itaru Kato, Jiro Kikuchi, Yusuke Furukawa, Yasuhiro Maeda, Koshi Akahane, Hiroko Honna-Oshiro, Kumiko Goi, Keiko Kagami, Shinya Kimura, Yuko Sato, Seiichi Okabe, Akira Niwa, Kenichiro Watanabe, Tatsutoshi Nakahata, Toshio Heike, Kanji Sugita, Takeshi Inukai Specific Antileukemic Activity of PD0332991, a CDK4/6 Inhibitor, against Philadelphia Chromosome-Positive Lymphoid Leukemia Specific Antileukemic Activity of PD0332991, a CDK4/6 Inhibitor, against Philadelphia Chromosome-Positive Lymphoid Leukemia Specific Antileukemic Activity of PD0332991, a CDK4/6 Inhibitor, against Philadelphia Chromosome-Positive Lymphoid Leukemia MOLECULAR CANCER THERAPEUTICS, 15, 1, 94-105 MOLECULAR CANCER THERAPEUTICS, 15, 1, 94-105 MOLECULAR CANCER THERAPEUTICS, 15, 1, 94-105 2016/01 Refereed English Research paper(scientific journal) Disclose to all
Katsutsugu Umeda, Satoshi Saida, Hideki Yamaguchi, Shinya Okamoto, Takeshi Okamoto, Itaru Kato, Hidefumi Hiramatsu, Tsuyoshi Imai, Takeshi Kodaira, Toshio Heike, Souichi Adachi, Ken-Ichiro Watanabe Katsutsugu Umeda, Satoshi Saida, Hideki Yamaguchi, Shinya Okamoto, Takeshi Okamoto, Itaru Kato, Hidefumi Hiramatsu, Tsuyoshi Imai, Takeshi Kodaira, Toshio Heike, Souichi Adachi, Ken-Ichiro Watanabe Katsutsugu Umeda, Satoshi Saida, Hideki Yamaguchi, Shinya Okamoto, Takeshi Okamoto, Itaru Kato, Hidefumi Hiramatsu, Tsuyoshi Imai, Takeshi Kodaira, Toshio Heike, Souichi Adachi, Ken-Ichiro Watanabe Central nervous system recurrence of desmoplastic small round cell tumor following aggressive multimodal therapy: A case report Central nervous system recurrence of desmoplastic small round cell tumor following aggressive multimodal therapy: A case report Central nervous system recurrence of desmoplastic small round cell tumor following aggressive multimodal therapy: A case report ONCOLOGY LETTERS, 11, 1, 856-860 ONCOLOGY LETTERS, 11, 1, 856-860 ONCOLOGY LETTERS, 11, 1, 856-860 2016/01 Refereed English Research paper(scientific journal) Disclose to all
Satoshi Saida, Masahiro Nakamura, Tsutomu Toki, Yoko Nishinaka-Arai, Kiminori Terui, Kenichi Yoshida, Seishi Ogawa, Tatsutoshi Nakahata, Toshio Heike, Ken-ichiro Watanabe, Akira Watanabe, Etsuro Ito Satoshi Saida, Masahiro Nakamura, Tsutomu Toki, Yoko Nishinaka-Arai, Kiminori Terui, Kenichi Yoshida, Seishi Ogawa, Tatsutoshi Nakahata, Toshio Heike, Ken-ichiro Watanabe, Akira Watanabe, Etsuro Ito Satoshi Saida, Masahiro Nakamura, Tsutomu Toki, Yoko Nishinaka-Arai, Kiminori Terui, Kenichi Yoshida, Seishi Ogawa, Tatsutoshi Nakahata, Toshio Heike, Ken-ichiro Watanabe, Akira Watanabe, Etsuro Ito Dysregulation of DNA Methylation Involves in Progression of Myeloid Leukemia in Down Syndrome Dysregulation of DNA Methylation Involves in Progression of Myeloid Leukemia in Down Syndrome Dysregulation of DNA Methylation Involves in Progression of Myeloid Leukemia in Down Syndrome BLOOD, 126, 23 BLOOD, 126, 23 BLOOD, 126, 23 2015/12 Refereed English Disclose to all
Satoshi Saida, Ken-ichiro Watanabe, Itaru Kato, Hisanori Fujino, Katsutsugu Umeda, Shinya Okamoto, Shinji Uemoto, Tomoro Hishiki, Hideo Yoshida, Shiro Tanaka, Souichi Adachi, Akira Niwa, Tatsutoshi Nakahata, Toshio Heike Satoshi Saida, Ken-ichiro Watanabe, Itaru Kato, Hisanori Fujino, Katsutsugu Umeda, Shinya Okamoto, Shinji Uemoto, Tomoro Hishiki, Hideo Yoshida, Shiro Tanaka, Souichi Adachi, Akira Niwa, Tatsutoshi Nakahata, Toshio Heike Satoshi Saida, Ken-ichiro Watanabe, Itaru Kato, Hisanori Fujino, Katsutsugu Umeda, Shinya Okamoto, Shinji Uemoto, Tomoro Hishiki, Hideo Yoshida, Shiro Tanaka, Souichi Adachi, Akira Niwa, Tatsutoshi Nakahata, Toshio Heike Prognostic significance of aminopeptidase-N (CD13) in hepatoblastoma Prognostic significance of aminopeptidase-N (CD13) in hepatoblastoma Prognostic significance of aminopeptidase-N (CD13) in hepatoblastoma PEDIATRICS INTERNATIONAL, 57, 4, 558-566 PEDIATRICS INTERNATIONAL, 57, 4, 558-566 PEDIATRICS INTERNATIONAL, 57, 4, 558-566 2015/08 Refereed English Research paper(scientific journal) Disclose to all
Daifu T, Umeda K, Kouzuki K, Hamabata T, Noudomi S, Saida S, Kato I, Hiramatsu H, Watanabe KI, Terada N, Imamura M, Ogawa O, Heike T, Adachi S Daifu T, Umeda K, Kouzuki K, Hamabata T, Noudomi S, Saida S, Kato I, Hiramatsu H, Watanabe KI, Terada N, Imamura M, Ogawa O, Heike T, Adachi S Daifu T, Umeda K, Kouzuki K, Hamabata T, Noudomi S, Saida S, Kato I, Hiramatsu H, Watanabe KI, Terada N, Imamura M, Ogawa O, Heike T, Adachi S The NOD/Shi-scid/IL-2Rγnull mice xenograft model recapitulates anaplastic large cell lymphoma dissemination to the bladder. The NOD/Shi-scid/IL-2Rγnull mice xenograft model recapitulates anaplastic large cell lymphoma dissemination to the bladder. The NOD/Shi-scid/IL-2Rγnull mice xenograft model recapitulates anaplastic large cell lymphoma dissemination to the bladder. Leukemia & Lymphoma, 24, 1-2 Leukemia & Lymphoma, 24, 1-2 Leukemia & Lymphoma, 24, 1-2 2014/10 Refereed English Disclose to all
Morishima Tatsuya, Watanabe Ken-ichiro, Niwa Akira, Hirai Hideyo, Saida Satoshi, Tanaka Takayuki, Kato Itaru, Umeda Katsutsugu, Hiramatsu Hidefumi, Saito Megumu K, Matsubara Kousaku, Adachi Souichi, Kobayashi Masao, Nakahata Tatsutoshi, Heike Toshio Morishima Tatsuya, Watanabe Ken-ichiro, Niwa Akira, Hirai Hideyo, Saida Satoshi, Tanaka Takayuki, Kato Itaru, Umeda Katsutsugu, Hiramatsu Hidefumi, Saito Megumu K, Matsubara Kousaku, Adachi Souichi, Kobayashi Masao, Nakahata Tatsutoshi, Heike Toshio Morishima Tatsuya, Watanabe Ken-ichiro, Niwa Akira, Hirai Hideyo, Saida Satoshi, Tanaka Takayuki, Kato Itaru, Umeda Katsutsugu, Hiramatsu Hidefumi, Saito Megumu K, Matsubara Kousaku, Adachi Souichi, Kobayashi Masao, Nakahata Tatsutoshi, Heike Toshio Genetic correction of HAX1 in induced pluripotent stem cells from a patient with severe congenital neutropenia improves defective granulopoiesis Genetic correction of HAX1 in induced pluripotent stem cells from a patient with severe congenital neutropenia improves defective granulopoiesis Genetic correction of HAX1 in induced pluripotent stem cells from a patient with severe congenital neutropenia improves defective granulopoiesis HAEMATOLOGICA, 99, 1, 19-27 HAEMATOLOGICA, 99, 1, 19-27 HAEMATOLOGICA, 99, 1, 19-27 2014/01 Refereed Disclose to all
Satoshi Saida, Ken-ichiro Watanabe, Aiko Sato-Otsubo, Kiminori Terui, Kenichi Yoshida, Yusuke Okuno, Tsutomu Toki, RuNan Wang, Yuichi Shiraishi, Satoru Miyano, Itaru Kato, Tatsuya Morishima, Hisanori Fujino, Katsutsugu Umeda, Hidefumi Hiramatsu, Souichi Adachi, Etsuro Ito, Seishi Ogawa, Mamoru Ito, Tatsutoshi Nakahata, Toshio Heike Satoshi Saida, Ken-ichiro Watanabe, Aiko Sato-Otsubo, Kiminori Terui, Kenichi Yoshida, Yusuke Okuno, Tsutomu Toki, RuNan Wang, Yuichi Shiraishi, Satoru Miyano, Itaru Kato, Tatsuya Morishima, Hisanori Fujino, Katsutsugu Umeda, Hidefumi Hiramatsu, Souichi Adachi, Etsuro Ito, Seishi Ogawa, Mamoru Ito, Tatsutoshi Nakahata, Toshio Heike Satoshi Saida, Ken-ichiro Watanabe, Aiko Sato-Otsubo, Kiminori Terui, Kenichi Yoshida, Yusuke Okuno, Tsutomu Toki, RuNan Wang, Yuichi Shiraishi, Satoru Miyano, Itaru Kato, Tatsuya Morishima, Hisanori Fujino, Katsutsugu Umeda, Hidefumi Hiramatsu, Souichi Adachi, Etsuro Ito, Seishi Ogawa, Mamoru Ito, Tatsutoshi Nakahata, Toshio Heike Clonal selection in xenografted TAM recapitulates the evolutionary process of myeloid leukemia in Down syndrome Clonal selection in xenografted TAM recapitulates the evolutionary process of myeloid leukemia in Down syndrome Clonal selection in xenografted TAM recapitulates the evolutionary process of myeloid leukemia in Down syndrome BLOOD, 121, 21, 4377-4387 BLOOD, 121, 21, 4377-4387 BLOOD, 121, 21, 4377-4387 2013/05 Refereed English Research paper(scientific journal) Disclose to all
Saida Satoshi, Kato Itaru, Inukai Takeshi, Nemoto Atsushi, Sugita Kanji, Maeda Yasuhiro, Niwa Akira, Watanabe Ken-ichiro, Nakahata Tatsutoshi, Heike Toshio Saida Satoshi, Kato Itaru, Inukai Takeshi, Nemoto Atsushi, Sugita Kanji, Maeda Yasuhiro, Niwa Akira, Watanabe Ken-ichiro, Nakahata Tatsutoshi, Heike Toshio Saida Satoshi, Kato Itaru, Inukai Takeshi, Nemoto Atsushi, Sugita Kanji, Maeda Yasuhiro, Niwa Akira, Watanabe Ken-ichiro, Nakahata Tatsutoshi, Heike Toshio PD0332991, a CDK4/6 Inhibitor, Has An Anti-Leukemic Activity Against Ph+ Leukemia with T315I Mutation in Bcr-Abl; In Vivo Analysis Using Xenograft Mice Model PD0332991, a CDK4/6 Inhibitor, Has An Anti-Leukemic Activity Against Ph+ Leukemia with T315I Mutation in Bcr-Abl; In Vivo Analysis Using Xenograft Mice Model PD0332991, a CDK4/6 Inhibitor, Has An Anti-Leukemic Activity Against Ph+ Leukemia with T315I Mutation in Bcr-Abl; In Vivo Analysis Using Xenograft Mice Model BLOOD, 118, 21, 1105-1106 BLOOD, 118, 21, 1105-1106 BLOOD, 118, 21, 1105-1106 2011/11/18 Refereed Disclose to all
Itaru Kato, Akira Niwa, Megumu Saito, Hisanori Fujino, Satoshi Saida, Hidefumi Hiramatsu, Koichi Oshima, Mamoru Ito, Souichi Adachi, Toshio Heike, Tatsutoshi Nakahata Itaru Kato, Akira Niwa, Megumu Saito, Hisanori Fujino, Satoshi Saida, Hidefumi Hiramatsu, Koichi Oshima, Mamoru Ito, Souichi Adachi, Toshio Heike, Tatsutoshi Nakahata Itaru Kato, Akira Niwa, Megumu Saito, Hisanori Fujino, Satoshi Saida, Hidefumi Hiramatsu, Koichi Oshima, Mamoru Ito, Souichi Adachi, Toshio Heike, Tatsutoshi Nakahata Establishment of a Novel CNS Infiltrated Xenograft Model through Engraftment of Patient-Derived Acute Lymphoblastic Leukemic Cells Into NOD/SCID/gamma c (Null) Mouse Establishment of a Novel CNS Infiltrated Xenograft Model through Engraftment of Patient-Derived Acute Lymphoblastic Leukemic Cells Into NOD/SCID/gamma c (Null) Mouse Establishment of a Novel CNS Infiltrated Xenograft Model through Engraftment of Patient-Derived Acute Lymphoblastic Leukemic Cells Into NOD/SCID/gamma c (Null) Mouse BLOOD, 116, 21, 1332-1332 BLOOD, 116, 21, 1332-1332 BLOOD, 116, 21, 1332-1332 2010/11 Refereed English Disclose to all

  • <<
  • >>
Title language:
Misc
Author Author(Japanese) Author(English) Title Title(Japanese) Title(English) Bibliography Bibliography(Japanese) Bibliography(English) Publication date Refereed paper Language Publishing type Disclose
上月 景弘, 才田 聡, 平松 英文, 梅田 雄嗣, 八木 英哉, 平家 俊男, 足立 壯一 上月 景弘, 才田 聡, 平松 英文, 梅田 雄嗣, 八木 英哉, 平家 俊男, 足立 壯一 上月 景弘, 才田 聡, 平松 英文, 梅田 雄嗣, 八木 英哉, 平家 俊男, 足立 壯一 TKIで多様な副作用を呈したPh1 double positive ALLの一例(A case of severe complicating disease associated with tyrosine kinase inhibitor (TKI) in the treatment of Ph1 double positive ALL) TKIで多様な副作用を呈したPh1 double positive ALLの一例(A case of severe complicating disease associated with tyrosine kinase inhibitor (TKI) in the treatment of Ph1 double positive ALL) TKIで多様な副作用を呈したPh1 double positive ALLの一例(A case of severe complicating disease associated with tyrosine kinase inhibitor (TKI) in the treatment of Ph1 double positive ALL) 日本小児血液・がん学会雑誌, 51, 4, 303-303 日本小児血液・がん学会雑誌, 51, 4, 303-303 日本小児血液・がん学会雑誌, 51, 4, 303-303 2014/10 English Disclose to all
Satoshi Saida, Ken-Ichiro Watanabe, Shinya Okamoto, Shinji Uemoto, Tomoro Hishiki, Itaru Kato, Shiro Tanaka, Souichi Adachi, Toshio Heike Satoshi Saida, Ken-Ichiro Watanabe, Shinya Okamoto, Shinji Uemoto, Tomoro Hishiki, Itaru Kato, Shiro Tanaka, Souichi Adachi, Toshio Heike Satoshi Saida, Ken-Ichiro Watanabe, Shinya Okamoto, Shinji Uemoto, Tomoro Hishiki, Itaru Kato, Shiro Tanaka, Souichi Adachi, Toshio Heike PROGNOSTIC SIGNIFICANCE OF APN/CD13 IN HEPATOBLASTOMA PROGNOSTIC SIGNIFICANCE OF APN/CD13 IN HEPATOBLASTOMA PROGNOSTIC SIGNIFICANCE OF APN/CD13 IN HEPATOBLASTOMA PEDIATRIC BLOOD & CANCER, 57, 5, 781-781 PEDIATRIC BLOOD & CANCER, 57, 5, 781-781 PEDIATRIC BLOOD & CANCER, 57, 5, 781-781 2011/11 English Research paper, summary (international conference) Disclose to all
才田聡, 渡邉健一郎, 藤野寿典, 足立壮一, 平家俊男 才田聡, 渡邉健一郎, 藤野寿典, 足立壮一, 平家俊男 免疫不全マウスを用いたTAM/AMKLの病態解析 免疫不全マウスを用いたTAM/AMKLの病態解析 第28回京都大学小児血液腫瘍研究会 第28回京都大学小児血液腫瘍研究会 2010/03 Disclose to all
河田紗耶架, 才田聡, 田中篤志, 北誠, 藤野寿典, 松原央, 渡邊健一郎, 足立壮一, 仲俣岳晴, 中山富貴, 戸口田淳也, 溝脇尚志 河田紗耶架, 才田聡, 田中篤志, 北誠, 藤野寿典, 松原央, 渡邊健一郎, 足立壮一, 仲俣岳晴, 中山富貴, 戸口田淳也, 溝脇尚志 多発骨転移を伴った右腸骨原発Ewing 肉腫の15 才女児例 多発骨転移を伴った右腸骨原発Ewing 肉腫の15 才女児例 第20 回小児固形腫瘍研究会(2010.3.28 京都) 第20 回小児固形腫瘍研究会(2010.3.28 京都) 2010 Refereed Japanese Disclose to all
才田聡, 藤野寿典, 甲原貴子, 渡邉健一郎, 田中篤志, 松原央, 足立壮一, 中畑龍俊, 岡本晋弥, 山内智香子, 秋山祐一 才田聡, 藤野寿典, 甲原貴子, 渡邉健一郎, 田中篤志, 松原央, 足立壮一, 中畑龍俊, 岡本晋弥, 山内智香子, 秋山祐一 才田聡, 藤野寿典, 甲原貴子, 渡邉健一郎, 田中篤志, 松原央, 足立壮一, 中畑龍俊, 岡本晋弥, 山内智香子, 秋山祐一 胆道原発横紋筋肉腫の1例 胆道原発横紋筋肉腫の1例 胆道原発横紋筋肉腫の1例 日本小児科学会京都地方会会報, 40, 1, 10 日本小児科学会京都地方会会報, 40, 1, 10 日本小児科学会京都地方会会報, 40, 1, 10 2009/05 Japanese Disclose to all
Title language:
Conference Activities & Talks
Title Title(Japanese) Title(English) Conference Conference(Japanese) Conference(English) Promotor Promotor(Japanese) Promotor(English) Date Language Assortment Disclose
Distinct Roles of GATA2 in Development and Evolution of CBFB-MYH11 AML Distinct Roles of GATA2 in Development and Evolution of CBFB-MYH11 AML Distinct Roles of GATA2 in Development and Evolution of CBFB-MYH11 AML 60th American Society of Hematology Annual Meeting & Exposition 第60回米国血液学会 60th American Society of Hematology Annual Meeting & Exposition 2018/12/01 English Oral presentation(general) Disclose to all
Evolution of Leukemia in Children with Down Syndrome Evolution of Leukemia in Children with Down Syndrome Evolution of Leukemia in Children with Down Syndrome The 6th JSH international Symposium The 6th JSH international Symposium The 6th JSH international Symposium 2015/05/22 English Symposium workshop panel(nominated) Disclose to all
Title language:
Awards
Title(Japanese) Title(English) Organization name(Japanese) Organization name(English) Date
日本血液学会奨励賞 The incentive award, The 76th Annual Meeting of the Japanese Society of hematology 日本血液学会 The Japanese Society of Hematology 2014/10/31
ASH abstract achievement award ASH abstract achievement award 米国血液学会 American society of hematology 2018/12/01
太田敬三記念賞 森永奉仕会 2020/06/02
External funds: competitive funds and Grants-in-Aid for Scientific Research (Kakenhi)
Type Position Title(Japanese) Title(English) Period
若手研究(B) Representative 異種移植モデルを用いたダウン症候群関連白血病の病態解析および特異的治療の基盤開発 (平成26年度分) 2014/04/01-2015/03/31
若手研究(B) Representative 異種移植モデルを用いたダウン症候群関連白血病の病態解析および特異的治療の基盤開発 (平成27年度分) 2015/04/01-2016/03/31
日本学術振興会海外特別研究員 Representative CBFB-MYH11陽性白血病の発症機序の解明および特異的治療の基盤開発 Pathogenetic and translational studies of leukemia associated with the fusion gene CBFB-MYH11 2016/09/28-2018/09/27
若手研究 Representative 小児最未分化型急性骨髄性白血病の病態解析および特異的治療の基盤開発 2020/04/01-2023/03/31
若手研究 Representative 小児最未分化型急性骨髄性白血病の病態解析および特異的治療の基盤開発 (2020年度分) 2020/04/01-2021/03/31